CELC
USDCelcuity Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$12.320
उच्च
$12.770
कम
$12.320
मात्रा
0.13M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
476.0M
उद्योग
जैव प्रौद्योगिकी
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
0.23M
एक्सचेंज
NCM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Celcuity with a Buy and maintains $27 price target.
Needham Reiterates Buy on Celcuity, Maintains $29 Price Target
Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $29 price target.
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the
Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call
MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its
संबंधित स्टॉक
ETG
Eaton Vance Tax-Advantaged Global Dividend Income Fund Common Shares of Beneficial Interest
ITW
Illinois Tool Works Inc.
OCS
Oculis Holding AG Ordinary shares
KIDS
OrthoPediatrics Corp.
GOCO
GoHealth Inc.
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।